Evan L Reynolds1, Brian C Callaghan2, Mousumi Banerjee3, Eva L Feldman4, Vijay Viswanathan5. 1. Department of Neurology, University of Michigan, Ann Arbor, MI 48108, USA. Electronic address: evanlr@umich.edu. 2. Department of Neurology, University of Michigan, Ann Arbor, MI 48108, USA. Electronic address: bcallagh@med.umich.edu. 3. Department of Biostatistics, University of Michigan, Ann Arbor, MI 48108, USA. Electronic address: mousumib@umich.edu. 4. Department of Neurology, University of Michigan, Ann Arbor, MI 48108, USA. Electronic address: efeldman@med.umich.edu. 5. M.V. Hospital for Diabetes and Prof M Viswanathan Diabetes Research Centre, Royapuram, Chennai, India.
Abstract
AIMS: To determine the association between the metabolic syndrome (MetS) and neuropathy in Chennai, India. METHODS: We recruited participants attending the M.V. Hospital for Diabetes. Neuropathy was defined using the Michigan Neuropathy Screening Instrument combined index and MetS was defined using the updated National Cholesterol Education Program criteria. Multivariable logistic regression models were used to assess the associations between individual metabolic components and neuropathy. RESULTS: Of the 652 participants (42% female and mean (SD) age of 45.5 (9.7)) included in the study, the prevalence of neuropathy was 9.8%. Neuropathy prevalence increased with worsening glycemic status (p < 0.01), but not as the number of MetS components increased (p = 0.12). Among normoglycemic participants, an increasing neuropathy trend was observed as the number of MetS components increased (p = 0.04). Multivariable logistic regression found that diabetes (OR:3.41,1.28-9.11) was associated with neuropathy, but waist circumference was not (OR:1.002,0.88-1.14). CONCLUSIONS: Similar to previous studies, diabetes was the most important metabolic risk factor for neuropathy in a population from Chennai, India. In contrast to other population-based studies, waist circumference was not associated with neuropathy. Whether the distribution of obesity affects nerves differently in Indian populations requires future studies with more precise anthropometric measures.
AIMS: To determine the association between the metabolic syndrome (MetS) and neuropathy in Chennai, India. METHODS: We recruited participants attending the M.V. Hospital for Diabetes. Neuropathy was defined using the Michigan Neuropathy Screening Instrument combined index and MetS was defined using the updated National Cholesterol Education Program criteria. Multivariable logistic regression models were used to assess the associations between individual metabolic components and neuropathy. RESULTS: Of the 652 participants (42% female and mean (SD) age of 45.5 (9.7)) included in the study, the prevalence of neuropathy was 9.8%. Neuropathy prevalence increased with worsening glycemic status (p < 0.01), but not as the number of MetS components increased (p = 0.12). Among normoglycemic participants, an increasing neuropathy trend was observed as the number of MetS components increased (p = 0.04). Multivariable logistic regression found that diabetes (OR:3.41,1.28-9.11) was associated with neuropathy, but waist circumference was not (OR:1.002,0.88-1.14). CONCLUSIONS: Similar to previous studies, diabetes was the most important metabolic risk factor for neuropathy in a population from Chennai, India. In contrast to other population-based studies, waist circumference was not associated with neuropathy. Whether the distribution of obesity affects nerves differently in Indian populations requires future studies with more precise anthropometric measures.
Authors: Brian C Callaghan; Rong Xia; Mousumi Banerjee; Nathalie de Rekeneire; Tamara B Harris; Anne B Newman; Suzanne Satterfield; Ann V Schwartz; Aaron I Vinik; Eva L Feldman; Elsa S Strotmeyer Journal: Diabetes Care Date: 2016-03-10 Impact factor: 19.112
Authors: P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service Journal: Neurology Date: 1993-04 Impact factor: 9.910
Authors: Rens Hanewinckel; Judith Drenthen; Symen Ligthart; Abbas Dehghan; Oscar H Franco; Albert Hofman; M Arfan Ikram; Pieter A van Doorn Journal: J Neurol Neurosurg Psychiatry Date: 2016-09-21 Impact factor: 10.154
Authors: Brian C Callaghan; Rong Xia; Evan Reynolds; Mousumi Banerjee; Charles Burant; Amy Rothberg; Rodica Pop-Busui; Emily Villegas-Umana; Eva L Feldman Journal: Clin Neurophysiol Date: 2018-01-16 Impact factor: 3.708
Authors: Farsad Afshinnia; Evan L Reynolds; Thekkelnaycke M Rajendiran; Tanu Soni; Jaeman Byun; Masha G Savelieff; Helen C Looker; Robert G Nelson; George Michailidis; Brian C Callaghan; Subramaniam Pennathur; Eva L Feldman Journal: Ann Clin Transl Neurol Date: 2022-08-03 Impact factor: 5.430
Authors: Evan L Reynolds; Gulcin Akinci; Mousumi Banerjee; Helen C Looker; Adam Patterson; Robert G Nelson; Eva L Feldman; Brian C Callaghan Journal: JCI Insight Date: 2021-05-24